Moderna (MRNA) PT Raised to $18 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Mani Foroohar raised the price target on Moderna (NASDAQ: MRNA) to $18.00 (from $15.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
